Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Study examines effects of higher NSAIDs dosages
Researchers test if higher doses alleviate foot pain in horses

A study carried out by researchers in America has examined whether higher-than-standard doses of non-steroidal anti-inflammatory drugs (NSAIDs) alleviate foot pain more efficiently.

To test this hypothesis, Jonathan Foreman DVM, MS, Dipl. ACVIM and his colleagues at the University of Illinois at Urbana-Champaign used a reversible heart bar shoe to allow sound horses to become temporarily lame. The pain subsides completely when researchers loosen the screw in the shoe to relieve foot pressure.

When the researchers tighten the screw in the shoe the pain level increases, as reflected by increasing heart rates. Following the regional anaesthesia application, the horses' heart rates dropped from 60 to 40 beats per minute (bpm).

In this study the scientists compared the effects of varying intravenous doses (half-dose, 1x, 2x) of flunixin meglumine; they used saline as a control. Ten sound horses wore a reversible heart bar shoe on the front left foot. Following treatment, the 1x and 2x doses improved heart rates for the 12-hour duration, whereas heart rates remained elevated in the control horses.

Heart rates in the horses given half-doses of flunixin did not decrease as much as those in the 1x and 2x horses, and they didn't remain low for as long. "They responded intermittently and not as obviously," Foreman commented. There was no difference in heart rate results between the horses receiving 1x or 2x flunixin meglumine.

Foreman concluded that the double dose was no more effective than the single dose and presented a higher risk of toxicity. The half-dose was less effective than the single dose; therefore, you can't rely on an anti-endotoxic half-dose to provide complete pain control for horses with painful hoof conditions such as laminitis.

Foreman summed the study up by saying: "More is not better and less is less effective."


Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.